Exponential growth in AtoZPay Solid growth in CreateApp Higher PaaS valuations in private company’s Spinout and dividend outside DTCC 100% of float naked short going into ex-dividend on 9/26/18 Weyland Tech Inc. (WEYL) really […]
There is a common saying, “where there is smoke there is fire” and it holds merit in many walks of life. So true is that of penny stock companies filing quarterly reports after long periods […]
Aug-Sept 2018 – Article by Mile Mile Secrets We devote thousands of hours of research to help you get Big Travel with Small Money. You support us by signing-up for credit cards through partner links […]
The commission is looking for an off-the-shelf tool to flag important social media posts on public sites across the web. Social media has become such a powerful tool it can affect the very institutions that underpin […]
The staff at PSInvestor want to adapt to the evolving technology that is available out there today and offer an effective means of reaching their readers without bombarding them with the old fashion email that […]
Awaiting name and ticker change to Verus Foods Securing non-dilutive Financing to fulfill their $109m backlog Received $78m contract in January of 2017 Announced a monthly agreement of up to $1 million of goods to […]
PSInvestor d/b/a www.PSInvestor.com (“Site,” “PSInvestor,” “us,” “our” or “we”) provide this website to you under the following terms and conditions (“Terms of Use”). BY CONTINUING TO USE THE SITE, YOU ARE INDICATING YOUR AGREEMENT TO […]
Highly specific rumors connect dots of deal making strategy Potentials suitors sitting on significant cash positions. Valuation gap between market cap and traditional metrics Testimonials of drug highlight strong case for approval Short interest […]
For new investors in the fun and wild penny stock realm, I guarantee most of them do not remember the infamous tale of CMKM Diamonds. Now 13 unlucky years later, there are still many shareholders […]
GALT’s upcoming phase 3 trial patient population will be without varices and includes an interim analysis. An interim analysis creates the opportunity for GALT to submit a New Drug Application (NDA) at the 18 month mark […]
PSInvestor.com